List of Tables
Table 1. Vasomotor Symptoms Treatment Market Trends
Table 2. Vasomotor Symptoms Treatment Market Drivers & Opportunity
Table 3. Vasomotor Symptoms Treatment Market Challenges
Table 4. Vasomotor Symptoms Treatment Market Restraints
Table 5. Global Vasomotor Symptoms Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Vasomotor Symptoms Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Vasomotor Symptoms Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Vasomotor Symptoms Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Vasomotor Symptoms Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Vasomotor Symptoms Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Vasomotor Symptoms Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Vasomotor Symptoms Treatment
Table 13. Global Vasomotor Symptoms Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasomotor Symptoms Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Vasomotor Symptoms Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Vasomotor Symptoms Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Vasomotor Symptoms Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Vasomotor Symptoms Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Vasomotor Symptoms Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Vasomotor Symptoms Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Vasomotor Symptoms Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Vasomotor Symptoms Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Vasomotor Symptoms Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Vasomotor Symptoms Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Vasomotor Symptoms Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Vasomotor Symptoms Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Vasomotor Symptoms Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Vasomotor Symptoms Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Vasomotor Symptoms Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Vasomotor Symptoms Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Vasomotor Symptoms Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Vasomotor Symptoms Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Vasomotor Symptoms Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Vasomotor Symptoms Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Vasomotor Symptoms Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Vasomotor Symptoms Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Vasomotor Symptoms Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Vasomotor Symptoms Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Vasomotor Symptoms Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Vasomotor Symptoms Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Vasomotor Symptoms Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Vasomotor Symptoms Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Vasomotor Symptoms Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Vasomotor Symptoms Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Vasomotor Symptoms Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Vasomotor Symptoms Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Vasomotor Symptoms Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Vasomotor Symptoms Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Vasomotor Symptoms Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Vasomotor Symptoms Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Vasomotor Symptoms Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Vasomotor Symptoms Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Vasomotor Symptoms Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Vasomotor Symptoms Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Vasomotor Symptoms Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer AG Company Information
Table 58. Bayer AG Introduction and Business Overview
Table 59. Bayer AG Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bayer AG Vasomotor Symptoms Treatment Product Offerings
Table 61. Bayer AG Recent Development
Table 62. Fervent Pharmaceuticals, LLC Company Information
Table 63. Fervent Pharmaceuticals, LLC Introduction and Business Overview
Table 64. Fervent Pharmaceuticals, LLC Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Fervent Pharmaceuticals, LLC Vasomotor Symptoms Treatment Product Offerings
Table 66. Fervent Pharmaceuticals, LLC Recent Development
Table 67. Astellas Pharma Inc. Company Information
Table 68. Astellas Pharma Inc. Introduction and Business Overview
Table 69. Astellas Pharma Inc. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Astellas Pharma Inc. Vasomotor Symptoms Treatment Product Offerings
Table 71. Astellas Pharma Inc. Recent Development
Table 72. Frazier Healthcare Partners Company Information
Table 73. Frazier Healthcare Partners Introduction and Business Overview
Table 74. Frazier Healthcare Partners Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Frazier Healthcare Partners Vasomotor Symptoms Treatment Product Offerings
Table 76. Frazier Healthcare Partners Recent Development
Table 77. Mitsubishi Tanabe Pharma Corporation Company Information
Table 78. Mitsubishi Tanabe Pharma Corporation Introduction and Business Overview
Table 79. Mitsubishi Tanabe Pharma Corporation Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Mitsubishi Tanabe Pharma Corporation Vasomotor Symptoms Treatment Product Offerings
Table 81. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 82. Eli Lilly and Company Company Information
Table 83. Eli Lilly and Company Introduction and Business Overview
Table 84. Eli Lilly and Company Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Eli Lilly and Company Vasomotor Symptoms Treatment Product Offerings
Table 86. Eli Lilly and Company Recent Development
Table 87. AbbVie Inc. Company Information
Table 88. AbbVie Inc. Introduction and Business Overview
Table 89. AbbVie Inc. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. AbbVie Inc. Vasomotor Symptoms Treatment Product Offerings
Table 91. AbbVie Inc. Recent Development
Table 92. AMAG Pharmaceuticals Inc. Company Information
Table 93. AMAG Pharmaceuticals Inc. Introduction and Business Overview
Table 94. AMAG Pharmaceuticals Inc. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. AMAG Pharmaceuticals Inc. Vasomotor Symptoms Treatment Product Offerings
Table 96. AMAG Pharmaceuticals Inc. Recent Development
Table 97. Emcure Pharmaceuticals Limited Company Information
Table 98. Emcure Pharmaceuticals Limited Introduction and Business Overview
Table 99. Emcure Pharmaceuticals Limited Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Emcure Pharmaceuticals Limited Vasomotor Symptoms Treatment Product Offerings
Table 101. Emcure Pharmaceuticals Limited Recent Development
Table 102. Merck & Co., Inc. Company Information
Table 103. Merck & Co., Inc. Introduction and Business Overview
Table 104. Merck & Co., Inc. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Merck & Co., Inc. Vasomotor Symptoms Treatment Product Offerings
Table 106. Merck & Co., Inc. Recent Development
Table 107. Novartis AG Company Information
Table 108. Novartis AG Introduction and Business Overview
Table 109. Novartis AG Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Novartis AG Vasomotor Symptoms Treatment Product Offerings
Table 111. Novartis AG Recent Development
Table 112. Novo Nordisk A/S Company Information
Table 113. Novo Nordisk A/S Introduction and Business Overview
Table 114. Novo Nordisk A/S Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Novo Nordisk A/S Vasomotor Symptoms Treatment Product Offerings
Table 116. Novo Nordisk A/S Recent Development
Table 117. Pfizer Inc. Company Information
Table 118. Pfizer Inc. Introduction and Business Overview
Table 119. Pfizer Inc. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Pfizer Inc. Vasomotor Symptoms Treatment Product Offerings
Table 121. Pfizer Inc. Recent Development
Table 122. Teva Pharmaceutical Industries Ltd. Company Information
Table 123. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 124. Teva Pharmaceutical Industries Ltd. Vasomotor Symptoms Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Teva Pharmaceutical Industries Ltd. Vasomotor Symptoms Treatment Product Offerings
Table 126. Teva Pharmaceutical Industries Ltd. Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Vasomotor Symptoms Treatment Downstream Customers
Table 130. Vasomotor Symptoms Treatment Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Vasomotor Symptoms Treatment Product Picture
Figure 2. Global Vasomotor Symptoms Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Vasomotor Symptoms Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Vasomotor Symptoms Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Vasomotor Symptoms Treatment Report Years Considered
Figure 7. Global Vasomotor Symptoms Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Vasomotor Symptoms Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vasomotor Symptoms Treatment Revenue in 2023
Figure 10. Vasomotor Symptoms Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Hormonal Therapies Picture
Figure 12. Non-Hormonal Therapies Picture
Figure 13. Others Picture
Figure 14. Global Vasomotor Symptoms Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Vasomotor Symptoms Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Vasomotor Symptoms Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Vasomotor Symptoms Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Vasomotor Symptoms Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Clinic
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Others
Figure 22. Global Vasomotor Symptoms Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Vasomotor Symptoms Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Vasomotor Symptoms Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 25. Global Vasomotor Symptoms Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Vasomotor Symptoms Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 27. North America Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Vasomotor Symptoms Treatment Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Vasomotor Symptoms Treatment Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Vasomotor Symptoms Treatment Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Vasomotor Symptoms Treatment Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Vasomotor Symptoms Treatment Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Vasomotor Symptoms Treatment Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Vasomotor Symptoms Treatment Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Vasomotor Symptoms Treatment Sales Volume (%), (2019-2030)
Figure 39. United States Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 45. China Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 47. China Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 57. India Vasomotor Symptoms Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Vasomotor Symptoms Treatment Sales Value by Type (%), 2023 VS 2030
Figure 59. India Vasomotor Symptoms Treatment Sales Value by Application (%), 2023 VS 2030
Figure 60. Vasomotor Symptoms Treatment Industrial Chain
Figure 61. Vasomotor Symptoms Treatment Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
